Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (33)
  • 2024 (40)
  • 2023 (73)
  • 2022 (54)
  • 2021 (32)
  • 2020 (8)
  • 2019 (2)

Subject

  • Drug Trafficking (4010)
  • Synthetic drugs (1064)
  • Guns/Weapons (989)
  • OCDETF/Task Force (810)
  • Fake Pills (654)
  • Arrests/Convictions - Major (603)
  • Guilty Plea (529)
  • Seizures (Drugs/Property) (456)
  • Prescription Drugs (364)
  • Overdose (321)
  • Major Law Enforcement Operation (267)
  • Take Back Day (246)
  • Task Forces/Task Force Officers (230)
  • Pharmaceuticals/Pharmacists/Physicians (224)
  • Money Laundering (203)
  • Gangs (196)
  • Outreach/Drug Prevention (184)
  • Fentanyl Awareness (152)
  • One Pill Can Kill (110)
  • HIDTA (103)
  • Press Conferences (68)
  • Narcoterrorism (53)
  • Prevention/Education - DEA websites GSAD, JTT etc (53)
  • Extraditions (50)
  • Public and Media Affairs - also see Congressional Affairs (50)
  • Dark Web- Internet Trafficking (29)
  • Asset Forfeiture (28)
  • International/Foreign Operations (28)
  • Red Ribbon (27)
  • Congressional Affairs (15)
  • Terrorism (14)
  • Fentanyl Free America (12)
  • Intergovernmental Affairs (9)
  • Other (8)
  • Campaigns (7)
  • Critical Incident (6)
  • Counterfeit Pills (5)
  • Intelligence Division - Intelligence Products (5)
  • Scam Calls (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Diversion Division (242)

Drug Name

  • Opioids (42)
  • Oxycodone (37)
  • Fentanyl (28)
  • Hydromorphone (13)
  • Synthetic Opioids (10)
  • Benzodiazepines (7)
  • Methamphetamine (6)
  • Morphine (6)
  • Amphetamines (3)
  • Methadone (3)
  • Steroids (3)
  • Cocaine (2)
  • Heroin (2)
  • Marijuana (Cannabis) (2)
  • Ketamine (1)
  • Marijuana Concentrates (1)

Field Division

  • Washington, DC (34)
  • New England (33)
  • New York (23)
  • Seattle (22)
  • Chicago (18)
  • Houston (15)
  • New Jersey (14)
  • Atlanta (13)
  • Miami (9)
  • New Orleans (8)
  • Sede (8)
  • San Francisco (7)
  • St. Louis (7)
  • El Paso (6)
  • Dallas (5)
  • Rocky Mountain (5)
  • Los Angeles (3)
  • Omaha (3)
  • Phoenix (3)
  • San Diego (3)
  • Louisville (2)
  • Detroit (1)
Clear All Results
PRESS RELEASE

Indianapolis Pharmacy Technician Charged with Controlled Substances Violations

Marzo 24, 2023
INDIANAPOLIS - A joint investigation by Drug Enforcement Administration-Indianapolis and the Indianapolis Metropolitan Police Department (IMPD) has led to the arrest of Zennon Gaines, a pharmacy technician from Indianapolis, who has been charged with multiple violations, including felony dealing and possession of a controlled substance by fraud/forgery. The joint investigation...
Marzo 24, 2023
PRESS RELEASE

Panama City Physician Pays $225,000 to Settle Allegations that He Overprescribed Controlled Substances

Marzo 21, 2023
PENSACOLA, Fla. – Dr. George Barrio, a pain management physician who formerly practiced medicine at the NeuroMedical Institute in Panama City, agreed to pay $225,000 to resolve allegations that he unlawfully prescribed opioids and other controlled substances to patients. The settlement was announced by Jason R. Coody, United States Attorney...
Marzo 21, 2023
PRESS RELEASE

Rocky Mountain Diversion Investigator Named “Outstanding Citizen of the Year”

Marzo 17, 2023
Bozeman, Mont. – Rocky Mountain Division Diversion Investigator (DI) Aaron St. Peter was recently named “Outstanding Citizen of the Year” at the Montana Narcotic’s Officers Association (MNOA) Conference in Bozeman. DI St. Peter was nominated by a colleague from the Montana Department of Justice, Criminal Investigation Division (MT CID). The...
Marzo 17, 2023
PRESS RELEASE

Greenwood Village Psychiatrist Pleads Guilty to Illegal Distribution of Controlled Substances and Financial Crimes

Marzo 09, 2023
DENVER – Howard Weiss of Greenwood Village pleaded guilty on March 8, 2023 to distributing a controlled substance outside the usual course of professional practice and for no legitimate medical purpose, structuring financial transactions in a way to evade reporting requirements, and engaging in monetary transactions greater than $10,000 in...
Marzo 09, 2023
PRESS RELEASE

Laurence Doud, Former CEO of Pharmaceutical Distributor, Sentenced to 27 Months in Prison for Conspiring to Unlawfully Distribute Controlled Substances and Defrauding the DEA

Marzo 08, 2023
Damian Williams, the United States Attorney for the Southern District of New York, announced that LAURENCE F. DOUD III, the former Chief Executive Officer of Rochester Drug Co-Operative, Inc. (“RDC”), was sentenced today in Manhattan federal court to 27 months in prison for conspiring to unlawfully distribute oxycodone and fentanyl...
Marzo 08, 2023
PRESS RELEASE

Indiana Man Sentenced to 5 Years' Probation for Obtaining a Controlled Substance by Deception

Marzo 08, 2023
FORT WAYNE, Ind. – Alfred A. Cooke, Assistant Special Agent in Charge of Drug Enforcement Administration-Merrillville, Indiana, and U.S. Attorney Clifford D. Johnson for the Northern District of Indiana announced that Lucian Boboia, age 49, of Phoenix, Arizona, was sentenced before U.S. District Court Judge Holly A. Brady after pleading...
Marzo 08, 2023
PRESS RELEASE

DOJ and Lincoln Pharmacy in Tacoma Settle Allegations the Pharmacy Failed to Follow the Controlled Substances Act

Febrero 28, 2023
SEATTLE – The U.S. Attorney’s Office and Lincoln Pharmacy in Tacoma have reached a settlement agreement over inspection findings by the Drug Enforcement Administration that Lincoln had failed to comply with some of the administrative requirements of the Controlled Substances Act (CSA). Lincoln Pharmacy will pay the United States $80,000...
Febrero 28, 2023
PRESS RELEASE

Former Nurse Indicted for Drug Diversion from Boston Hospital

Febrero 27, 2023
BOSTON – A former nurse has been indicted by a federal grand jury in Boston for allegedly diverting opioids from a Boston-area hospital. Andrea Falzano, 38, of Winchester, was indicted on three counts of unlawfully obtaining controlled substances by fraud, deception and subterfuge. Falzano was arrested this morning and will...
Febrero 27, 2023
PRESS RELEASE

Physician Agrees to $190,731 Settlement Relating to Controlled Substances Act Claims

Febrero 24, 2023
PENSACOLA, Fla. – Timothy Ramsden, of Panama City, Florida, practicing at The Anti-Aging Clinic of Northwest Florida, settled potential violations of the Controlled Substances Act by agreeing to pay a fine of $190,731 and surrendering his Drug Enforcement Administration (DEA) registration for Schedule II and IIN controlled substances for a...
Febrero 24, 2023
PRESS RELEASE

Queens Pharmacist Pleads Guilty to Illegally Distributing Oxycodone and Filing False Tax Returns

Febrero 17, 2023
BROOKLYN – Daniel E. Russo pleaded guilty today in federal court in Brooklyn to conspiracy to distribute and possess with intent to distribute oxycodone, distribution and possession of oxycodone, and nine counts of filing false personal and corporate tax returns. The proceeding was held before United States District Judge Dora...
Febrero 17, 2023
Showing 131 - 140 of 242 results

Paginación

  • Primera página «
  • Página anterior ‹
  • Página 10
  • Página 11
  • Página 12
  • Página 13
  • Current page 14
  • Página 15
  • Página 16
  • Página 17
  • Página 18
  • Siguiente página ›
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster